The DOI matches its Crossref record; 155 of the 155 references it cites were found in a registry or an index.
ATP binding cassette transporters and drug resistance in breast cancer.
Abstract
Resistance to chemotherapy is a critical issue in the management of breast cancer patients. The nature of clinical drug resistance is likely to be multifactorial. However, in the last decade considerable attention has been dedicated to the role played by membrane transporter proteins belonging to the ATP binding cassette protein superfamily, and in particular by the MDR1 product P-glycoprotein (Pgp) and the multidrug resistance protein (MRP1). Heterogeneity of results is a common feature of studies evaluating the expression and prognostic role of these proteins, due to both methodological and biological factors. Nonetheless, Pgp and MRP1 are detected in a significant proportion of untreated breast cancers (on average 40 and 50% respectively, by immunohistochemistry), without a clear and consistent association with cancer stage. Exposure to chemotherapy increases the expression of both proteins. In vitro studies on primary cultures of breast cancer cells obtained at surgery consistently show an association between Pgp (protein) or MDR1 (mRNA) expression and resistance to chemotherapy. However, the correlation with clinical drug resistance is not as well defined. A stronger association of Pgp/MDR1 with response rates has been observed when expression or an increase in expression are detected immediately following chemotherapy. Correlations with prognosis appear more evident in studies using immunohistochemistry, in adjuvant and neoadjuvant settings. Evidence of clinical reversal of drug resistance by verapamil suggests a functional role of Pgp in drug resistance, although the significance of the evidence is generally weakened by poor trial designs. Future studies should take into account the multifactorial nature of drug resistance in breast cancer and use standardized approaches with adequate controls. Expression studies should be complemented by well-designed trials of drug-resistance reversal using target-specific chemosensitizing agents, and relating the results to the levels of expression of the target proteins.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cancer: Principles and Practice of Oncology.
(1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-114-9-819_4 · Cited by 8,516
A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants
Juliano, R. L., & Ling, V. (1976) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(76)90160-7 · Cited by 3,296
Thiebaut, F., Tsuruo, T., Hamada, H., Gottesman, M. M., Pastan, I., & Willingham, M. C. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.21.7735 · Cited by 2,777
Mechanisms of Cancer Drug Resistance
Gottesman, M. M. (2002) · Annual Review of Medicine · doi:10.1146/annurev.med.53.082901.103929 · Cited by 2,643
A multidrug resistance transporter from human MCF-7 breast cancer cells
Doyle, L. A., Yang, W., Abruzzo, L. V., Krogmann, T., Gao, Y., Rishi, A. K., & Ross, D. D. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.26.15665 · Cited by 2,322
Cancer: Principles and Practice of Oncology.
(1988) · Annals of Internal Medicine · doi:10.7326/0003-4819-108-3-506_5 · Cited by 1,900
A family of drug transporters: the multidrug resistance-associated proteins
Borst, P., Evers, R., Kool, M., & Wijnholds, J. (2000) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/92.16.1295 · Cited by 1,751
Cordon-Cardo, C., O'Brien, J. P., Casals, D., Rittman-Grauer, L., Biedler, J. L., Melamed, M. R., & Bertino, J. R. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.2.695 · Cited by 1,750
The Human ATP-Binding Cassette (ABC) Transporter Superfamily
Dean, M., Rzhetsky, A., & Allikmets, R. (2001) · Genome Research · doi:10.1101/gr.184901 · Cited by 1,748
Expression of a multidrug-resistance gene in human tumors and tissues.
Fojo, A. T., Ueda, K., Slamon, D. J., Poplack, D. G., Gottesman, M. M., & Pastan, I. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.1.265 · Cited by 1,544
Expression of Multidrug Resistance Gene in Human Cancers
Goldstein, L. J., Galski, H., Fojo, A., Willingham, M., Lai, S.-L., Gazdar, A., Pirker, R., Green, A., Crist, W., Brodeur, G. M., et al. (1989) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/81.2.116 · Cited by 1,290
The Human ATP-Binding Cassette (ABC) Transporter Superfamily
Dean, M. (2001) · Genome Research · doi:10.1101/gr.gr-1649r · Cited by 1,113
Cordon-Cardo, C., O'Brien, J. P., Boccia, J., Casals, D., Bertino, J. R., & Melamed, M. R. (1990) · Journal of Histochemistry & Cytochemistry · doi:10.1177/38.9.1974900 · Cited by 1,062
Gros, P., Croop, J., & Housman, D. (1986) · Cell · doi:10.1016/0092-8674(86)90594-5 · Cited by 1,031
Chaudhary, P. M., & Roninson, I. B. (1991) · Cell · doi:10.1016/0092-8674(91)90141-k · Cited by 934
Leier, I., Jedlitschky, G., Buchholz, U., Cole, S. P., Deeley, R. G., & Keppler, D. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)46856-1 · Cited by 853
Miyake, K., Mickley, L. A., Litman, T., Zhan, Z., Robey, R. W., Cristensen, B., Brangi, M., Greenberger, L., Dean, M. C., Fojo, T., et al. (1999) · PubMed · Cited by 823
Allikmets, R., Schriml, L. M., Hutchinson, A. A., Romano-Spica, V., & Dean, M. C. (1998) · PubMed · Cited by 798
Pharmacological characterization of multidrug resistant MRP-transfected human tumor cells.
Cole, S. P. C., Sparks, K. E., Fraser, K., Loe, D. W., Grant, C. E., Wilson, G. M., & Deeley, R. G. (1994) · PubMed · Cited by 770
Biedler, J. L., & Riehm, H. (1970) · PubMed · Cited by 747
Greenberg, P. A., Hortobagyi, G. N., Smith, T. L., Ziegler, L. D., Frye, D. K., & Buzdar, A. U. (1996) · Journal of Clinical Oncology · doi:10.1200/jco.1996.14.8.2197 · Cited by 738
Active outward transport of daunomycin in resistant ehrlich ascites tumor cells
Danø, K. (1973) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(73)90191-0 · Cited by 723
Is the multidrug transporter a flippase?
Higgins, C. F., & Gottesman, M. M. (1992) · Trends in Biochemical Sciences · doi:10.1016/0968-0004(92)90419-a · Cited by 722
Reduced permeability in CHO cells as a mechanism of resistance to colchicine
Ling, V., & Thompson, L. H. (1974) · Journal of Cellular Physiology · doi:10.1002/jcp.1040830114 · Cited by 686
Isolation of human mdr DNA sequences amplified in multidrug-resistant KB carcinoma cells.
Roninson, I. B., Chin, J. E., Choi, K. G., Gros, P., Housman, D. E., Fojo, A., Shen, D. W., Gottesman, M. M., & Pastan, I. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.12.4538 · Cited by 686
The human multidrug resistance-associated protein MRP is a plasma membrane drug-efflux pump.
Zaman, G. J., Flens, M. J., van Leusden, M. R., de Haas, M., Mülder, H. S., Lankelma, J., Pinedo, H. M., Scheper, R. J., Baas, F., & Broxterman, H. J. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.19.8822 · Cited by 680
The multidrug resistance protein family
Borst, P., Evers, R., Kool, M., & Wijnholds, J. (1999) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/s0005-2736(99)00167-4 · Cited by 648
Müller, M., Meijer, C., Zaman, G. J., Borst, P., Scheper, R. J., Mulder, N. H., de Vries, E. G., & Jansen, P. L. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.26.13033 · Cited by 617
Thiebaut, F., Tsuruo, T., Hamada, H., Gottesman, M. M., Pastan, I., & Willingham, M. C. (1989) · Journal of Histochemistry & Cytochemistry · doi:10.1177/37.2.2463300 · Cited by 604
An inventory of the human ABC proteins
Klein, I., Sarkadi, B., & Váradi, A. (1999) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/s0005-2736(99)00161-3 · Cited by 582
BindingDB (2013) · PubMed · doi:10.7270/q2q81fck · Cited by 571
Teicher, B. A. (1994) · Cancer and Metastasis Reviews · doi:10.1007/bf00689633 · Cited by 563
Loe, D. W., Almquist, K. C., Deeley, R. G., & Cole, S. P. C. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.16.9675 · Cited by 560
Functional imaging of multidrug-resistant P-glycoprotein with an organotechnetium complex.
Piwnica-Worms, D. R., Chiu, M. L., Budding, M., Kronauge, J. F., Kramer, R. A., & Croop, J. M. (1993) · PubMed · Cited by 512
Croop, J. M., Raymond, M., Haber, D., Devault, A., Arceci, R. J., Gros, P., & Housman, D. E. (1989) · Molecular and Cellular Biology · doi:10.1128/mcb.9.3.1346 · Cited by 463
Interrelationship Between Substrates and Inhibitors of Human CYP3A and P-Glycoprotein
Kirn, R. B., Wandel, C., Leake, B., Cvetkovic, M., Fromm, M. F., Dempsey, P. J., Roden, M. M., Belas, F., Chaudhary, A. K., Roden, D. M., et al. (1999) · Pharmaceutical Research · doi:10.1023/a:1018877803319 · Cited by 454
Antifolate resistance mediated by the multidrug resistance proteins MRP1 and MRP2.
Hooijberg, J. H., Broxterman, H. J., Kool, M., Assaraf, Y. G., Peters, G. J., Noordhuis, P., Scheper, R. J., Borst, P., Pinedo, H. M., & Jansen, G. (1999) · PubMed · Cited by 442
Trock, B. J., Leonessa, F., & Clarke, R. (1997) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/89.13.917 · Cited by 434
Self-citationWijnholds, J., Evers, R., van Leusden, M. R., Mol, C. A. A. M., Zaman, G. J. R., Mayer, U., Beijnen, J. H., Valk, M. V. D., Krimpenfort, P., & Borst, P. (1997) · Nature Medicine · doi:10.1038/nm1197-1275 · Cited by 432
Bargou, R. C., Jürchott, K., Wagener, C., Bergmann, S., Metzner, S., Bommert, K., Mapara, M. Y., Winzer, K.-J., Dietel, M., Dörken, B., et al. (1997) · Nature Medicine · doi:10.1038/nm0497-447 · Cited by 423
Multicellular resistance: a paradigm for clinical resistance?
Desoize, B. (2000) · Critical Reviews in Oncology/Hematology · doi:10.1016/s1040-8428(00)00086-x · Cited by 400
Chin, K. V., Tanaka, S., Darlington, G., Pastan, I., & Gottesman, M. M. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)40219-6 · Cited by 393
Photosensitized labeling of a functional multidrug transporter in living drug-resistant tumor cells.
Raviv, Y., Pollard, H. B., Bruggemann, E. P., Pastan, I., & Gottesman, M. M. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)39690-5 · Cited by 387
Beck, W. T., Grogan, T. M., Willman, C. L., Cordon‐Cardo, C., Parham, D. M., Kuttesch, J. F., Andreeff, M., Bates, S. E., Berard, C. W., Boyett, J. M., et al. (1996) · PubMed · Cited by 384
Chaudhary, P., Mechetner, E., & Roninson, I. (1992) · Blood · doi:10.1182/blood.v80.11.2735.2735 · Cited by 379
Chaudhary, P. M., & Roninson, I. B. (1993) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/85.8.632 · Cited by 360
Wijnholds, J., de Lange, E. C. M., Scheffer, G. L., van den Berg, D.-J., Mol, C. A. A. M., van der Valk, M., Schinkel, A. H., Scheper, R. J., Breimer, D. D., & Borst, P. (2000) · Journal of Clinical Investigation · doi:10.1172/jci8267 · Cited by 360
P-glycoprotein expression and function in circulating blood cells from normal volunteers
Klimecki, W., Futscher, B., Grogan, T., & Dalton, W. (1994) · Blood · doi:10.1182/blood.v83.9.2451.2451 · Cited by 353
Rosenberg, M. F., Callaghan, R., Ford, R. C., & Higgins, C. F. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.16.10685 · Cited by 345
Roninson, I. B., Abelson, H. T., Housman, D. E., Howell, N., & Varshavsky, A. (1984) · Nature · doi:10.1038/309626a0 · Cited by 332
The p53 Tumor Suppressor Gene: From Molecular Biology to Clinical Investigation
SOUSSI, T. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb06705.x · Cited by 332
P-Glycoproteins and Multidrug Resistance
Bellamy, W. T. (1996) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pa.36.040196.001113 · Cited by 319
JEDLITSCHKY, G., LEIER, I., BUCHHOLZ, U., HUMMEL-EISENBEISS, J., BURCHELL, B., & KEPPLER, D. (1997) · Biochemical Journal · doi:10.1042/bj3270305 · Cited by 303
Mechetner, E. B., Kyshtoobayeva, A. S., Zonis, S., Kim, H. J., Stroup, R., Garcia, R., Parker, R. J., & Fruehauf, J. P. (1998) · PubMed · Cited by 291
Harris, J. W., Rahman, A., Kim, B.-R., Guengerich, F. P., & Collins, J. M. (1994) · PubMed · Cited by 283
ATP-dependent 17β-Estradiol 17-(β-D-Glucuronide) Transport by Multidrug Resistance Protein (MRP)
Loe, D. W., Almquist, K. C., Cole, S. P. C., & Deeley, R. G. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.16.9683 · Cited by 267
Ishikawa, T., Bao, J.-J., Yamane, Y., Akimaru, K., Frindrich, K., Wright, C. D., & Kuo, M. T. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.25.14981 · Cited by 266
Lorico, A., Rappa, G., Finch, R. A., Yang, D. D., Flavell, R. A., & Sartorelli, A. C. (1997) · PubMed · Cited by 241
Van der Valk, P., van Kalken, C. K., Ketelaars, H., Broxterman, H. J., Scheffer, G., Kuiper, C. M., Tsuruo, T., Lankelma, J., Meijer, C. J. L. M., Pinedo, H. M., et al. (1990) · Annals of Oncology · doi:10.1093/oxfordjournals.annonc.a057676 · Cited by 239
The Role of Drug Transporters at the Blood-Brain Barrier
de Boer, A. G., van der Sandt, I. C. J., & Gaillard, P. J. (2003) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.43.100901.140204 · Cited by 238
Ohga, T., Uchiumi, T., Makino, Y., Koike, K., Wada, M., Kuwano, M., & Kohno, K. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.11.5997 · Cited by 233
Breuninger, L. M., Paul, S., Gaughan, K., Miki, T., Chan, A. M.-L., Aaronson, S. A., & Kruh, G. D. (1995) · PubMed · Cited by 209
Bishop, J. F., Dewar, J., Toner, G. C., Smith, J., Tattersall, M. H. N., Olver, I. N., Ackland, S., Kennedy, I., Goldstein, D., Gurney, H., et al. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.8.2355 · Cited by 209
Verrelle, P., Frederic, M., Fonck, Y., Feillel, V., Dionet, C., Kwiatkowski, F., Plagne, R., & Chassagne, J. (1991) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/83.2.111 · Cited by 202
Wijnholds, J., Scheffer, G. L., van der Valk, M., van der Valk, P., Beijnen, J. H., Scheper, R. J., & Borst, P. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.5.797 · Cited by 202
Salmon, S. E., Grogan, T. M., Miller, T., Scheper, R., & Dalton, W. S. (1989) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/81.9.696 · Cited by 196
Rocchi, E., Khodjakov, A., Volk, E. L., Yang, C.-H., Litman, T., Bates, S. E., & Schneider, E. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.2590 · Cited by 184
Loo, T. W., & Clarke, D. M. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.c100467200 · Cited by 173
Ito, K.-I., Olsen, S. L., Qiu, W., Deeley, R. G., & Cole, S. P. C. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m011246200 · Cited by 166
Thottassery, J. V., Zambetti, G. P., Arimori, K., Schuetz, E. G., & Schuetz, J. D. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.20.11037 · Cited by 163
The Structure of the Multidrug Resistance Protein 1 (MRP1/ABCC1)
Rosenberg, M. F., Mao, Q., Holzenburg, A., Ford, R. C., Deeley, R. G., & Cole, S. P. C. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m100176200 · Cited by 161
Visualization of multidrug resistance in vivo
Hendrikse, N. H., Franssen, E. J. F., van der Graaf, W. T. A., Vaalburg, W., & de Vries, E. G. E. (1999) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s002590050390 · Cited by 161
Steroid Transport, Accumulation, and Antagonism of P-Glycoprotein in Multidrug-Resistant Cells
Barnes, K. M., Dickstein, B., Cutler, G. B., Fojo, T., & Bates, S. E. (1996) · Biochemistry · doi:10.1021/bi952380k · Cited by 154
Nooter, K., de la Rivière, G. B., Look, M. P., van Wingerden, K. E., Henzen-Logmans, S. C., Scheper, R. J., Flens, M. J., Klijn, J. G. M., Stoter, G., & Foekens, J. A. (1997) · British Journal of Cancer · doi:10.1038/bjc.1997.414 · Cited by 153
Ciarmiello, A., Vecchio, S. D., Silvestro, P., Potena, M. I., Carriero, M. V., Thomas, R., Botti, G., D’Aiuto, G., & Salvatore, M. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.5.1677 · Cited by 149
Coley, H., Amos, W., Twentyman, P. R., & Workman, P. (1993) · British Journal of Cancer · doi:10.1038/bjc.1993.244 · Cited by 147
Transcriptional Activation of the MDR1 Gene by UV Irradiation
Hu, Z., Jin, S. V., & Scotto, K. W. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.4.2979 · Cited by 146
99mTc-sestamibi is a substrate for P-glycoprotein and the multidrug resistance-associated protein
Hendrikse, N. H., Franssen, E. J. F., van der Graaf, W., Meijer, C., Piers, D., Vaalburg, W., & de Vries, E. (1998) · British Journal of Cancer · doi:10.1038/bjc.1998.57 · Cited by 144
Loo, T. W., & Clarke, D. M. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.51.31945 · Cited by 143
Regulation of the multidrug resistance genes by stress signals.
Sukhai, M. A., & Piquette‐Miller, M. (2000) · PubMed · Cited by 143
Taxol resistance mediated by transfection of the liver-specific sister gene of P-glycoprotein.
Childs, S. J., Yeh, R. L., Hui, D., & Ling, V. W. T. (1998) · PubMed · Cited by 141
Transport of glutathione prostaglandin A conjugates by the multidrug resistance protein 1
Evers, R., Cnubben, N. H. P., Wijnholds, J., van Deemter, L., van BLADEREN, P. J., & Borst, P. (1997) · FEBS Letters · doi:10.1016/s0014-5793(97)01442-7 · Cited by 138
Cortisol is transported by the multidrug resistance gene product P-glycoprotein
van Kalken, C. K., Broxterman, H. J., Pinedo, H. M., Feller, N., Dekker, H., Lankelma, J., & Giaccone, G. (1993) · British Journal of Cancer · doi:10.1038/bjc.1993.54 · Cited by 136
Enhanced expression of the human multidrug resistance 1 gene in response to UV light irradiation.
Uchiumi, T., Kohno, K., Tanimura, H., Matsuo, K., Sato, S., Uchida, Y., & Kuwano, M. (1993) · PubMed · Cited by 136
Loo, T. W., & Clarke, D. M. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m007741200 · Cited by 134
Prognostic and predictive value of p53 and p21 in breast cancer
Elledge, R. M., & Allred, D. C. (1998) · Breast Cancer Research and Treatment · doi:10.1023/a:1006163101948 · Cited by 132
Germann, U. A., Ford, P. J., Shlyakhter, D., Mason, V. S., & Harding, M. W. (1997) · Anti-Cancer Drugs · doi:10.1097/00001813-199702000-00005 · Cited by 131
Lecureur, V., Sun, D., Hargrove, P., Schuetz, E. G., Kim, R. B., Lan, L.-B., & Schuetz, J. D. (2000) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)26438-5 · Cited by 128
Bottini, A., Berruti, A., Bersiga, A., Brizzi, M. P., Brunelli, A., Gorzegno, G., DiMarco, B., Aguggini, S., Bolsi, G., Cirillo, F., et al. (2000) · PubMed · Cited by 123
Belpomme, D., Gauthier, S., Pujade-Lauraine, É., Facchini, T., Goudier, M.-J., Krakowski, I., Netter-Pinon, G., Frénay, M., Gousset, C., MARIE, F.-N., et al. (2000) · Annals of Oncology · doi:10.1023/a:1026556119020 · Cited by 118
Interaction of tamoxifen with the multidrug resistance P-glycoprotein
Callaghan, R., & Higgins, C. F. (1995) · British Journal of Cancer · doi:10.1038/bjc.1995.59 · Cited by 115
Expression of drug resistance proteins in breast cancer, in relation to chemotherapy
Linn, S. C., Pinedo, H. M., van Ark-Otte, J., van der Valk, P., Hoekman, K., Honkoop, A. H., Vermorken, J. B., & Giaccone, G. (1997) · International Journal of Cancer · Cited by 112
Fischer, V., Rodríguez‐Gascón, A., Heitz, F., Tynes, R. E., Hauck, C., Cohen, D., & Vickers, A. E. M. (1998) · PubMed · Cited by 111
Linn, S., Honkoop, A. H., Hoekman, K., van der Valk, P., Pinedo, H. M., & Giaccone, G. (1996) · British Journal of Cancer · doi:10.1038/bjc.1996.316 · Cited by 110
Identification of Residues in the Drug-binding Domain of Human P-glycoprotein
Loo, T. W., & Clarke, D. M. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.50.35388 · Cited by 109
Wishart, G. C., Bissett, D., Paul, J., Jodrell, D. I., Harnett, A. N., Habeshaw, T., Kerr, D. J., Macham, M. A., Soukop, M., & Leonard, R. C. (1994) · Journal of Clinical Oncology · doi:10.1200/jco.1994.12.9.1771 · Cited by 102
Activation of human multidrug resistance-1 gene promoter in response to heat shock stress
Miyazaki, M., Kohno, K., Uchiumi, T., Tanimura, H., Matsuo, K.-I., Nasu, M., & Kuwano, M. (1992) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(92)91248-o · Cited by 95
MRP and MDR1 gene expression in primary breast carcinomas.
Filipits, M., Suchomel, R. W., Dekan, G., Haider, K., Valdimarsson, G., Depisch, D., & Pirker, R. (1996) · PubMed · Cited by 94
Multidrug-resistance phenotype of a subpopulation of T-lymphocytes without drug selection
Neyfakh, A. A., Serpinskaya, A. S., Chervonsky, A. V., Apasov, S. G., & Kazarov, A. R. (1989) · Experimental Cell Research · doi:10.1016/0014-4827(89)90318-2 · Cited by 94
P‐glycoprotein transports corticosterone and is photoaffinity‐labeled by the steroid
Wolf, D. C., & Horwitz, S. B. (1992) · International Journal of Cancer · doi:10.1002/ijc.2910520125 · Cited by 94
Double knockout of the MRP gene leads to increased drug sensitivity in vitro.
Lorico, A., Rappa, G., Flavell, R. A., & Sartorelli, A. C. (1996) · PubMed · Cited by 89
Loo, T. W., & Clarke, D. M. (1999) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/s0005-2736(99)00165-0 · Cited by 86
Sanfilippo, O., Ronchi, E., Marco, C. D., di Fronzo, G., & Silvestrini, R. (1991) · European Journal of Cancer and Clinical Oncology · doi:10.1016/0277-5379(91)90476-t · Cited by 84
Chen, W. S., Luker, K. E., Dahlheimer, J. L., Pica, C. M., Luker, G. D., & Piwnica-Worms, D. R. (2000) · Biochemical Pharmacology · doi:10.1016/s0006-2952(00)00341-5 · Cited by 82
Toppmeyer, D., Seidman, A. D., Pollak, M., Russell, C. A., Tkaczuk, K., Verma, S., Overmoyer, B. A., Garg, V., Ette, E., Harding, M. W., et al. (2002) · PubMed · Cited by 82
Prognostic relevance of P-glycoprotein expression in breast cancer
Linn, S., Giaccone, G., van Diest, P. J., Blokhuis, W. M. D., van der Valk, P., van Kalken, C. K., Kuiper, C. M., Pinedo, H. M., & Baak, J. P. A. (1995) · Annals of Oncology · doi:10.1093/oxfordjournals.annonc.a059284 · Cited by 82
Progesterone photoaffinity labels P-glycoprotein in multidrug-resistant human leukemic lymphoblasts.
Qian, X. D., & Beck, W. T. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)30575-6 · Cited by 81
Veneroni, S., Zaffaroni, N., Daidone, M. G., Benini, E., Villa, R., & Silvestrini, R. (1994) · European Journal of Cancer · doi:10.1016/0959-8049(94)90132-5 · Cited by 80
DeterminingMDR1/P-glycoprotein expression in breast cancer
Faneyte, I. F., Kristel, P., & van de Vijver, M. J. (2001) · International Journal of Cancer · Cited by 76
Phase I crossover study of paclitaxel with r-verapamil in patients with metastatic breast cancer.
Tolcher, A. W., Cowan, K. H., Solomon, D., Ognibene, F. P., Goldspiel, B. R., Chang, R., Noone, M., Denicoff, A. M., Barnes, C. S., Gossard, M. R., et al. (1996) · Journal of Clinical Oncology · doi:10.1200/jco.1996.14.4.1173 · Cited by 72
Loo, T. W., & Clarke, D. M. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m103498200 · Cited by 70
Anthracyclines modulate multidrug resistance protein (MRP) mediated organic anion transport
Heijn, M., Hooijberg, J. H., Scheffer, G. L., Szabó, G., Westerhoff, H. V., & Lankelma, J. (1997) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/s0005-2736(97)00003-5 · Cited by 70
Steroid hormones inhibit binding of alkaloid to multidrug resistance related P-glycoprotein
Naito, M., Yusa, K., & TSURUO, T. (1989) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(89)92830-1 · Cited by 70
Loo, T. W., & Clarke, D. M. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.022049799 · Cited by 70
Leonessa, F., Jacobson, M., Boyle, B., Lippman, J., McGarvey, M. L., & Clarke, R. C. (1994) · PubMed · Cited by 69
Self-citationGoldsmith, M. E., Gudas, J. M., Schneider, E., & Cowan, K. H. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.4.1894 · Cited by 67
Multidrug resistance protein in recurrent breast cancer
Nooter, K., de la Rivière, G. B., Klijn, J. G. M., Stoter, G., & Foekens, J. A. (1997) · The Lancet · doi:10.1016/s0140-6736(05)63876-7 · Cited by 65
The transporter associated with antigen processing TAP: structure and function
Lankat–Buttgereit, B., & Tampé, R. (1999) · FEBS Letters · doi:10.1016/s0014-5793(99)01676-2 · Cited by 63
Daoud, R., Michel, J., Gros, P., & Georges, E. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m009782200 · Cited by 63
Hu, X. F., Slater, A. A., Kantharidis, P., Rischin, D., Juneja, S., Rossi, R., Lee, G., Parkin, J. D., & Zalcberg, J. R. (1999) · Blood · doi:10.1182/blood.v93.12.4086 · Cited by 63
GSH-dependent Photolabeling of Multidrug Resistance Protein MRP1 (ABCC1) by [125I]LY475776
Mao, Q., Qiu, W., Weigl, K. E., Lander, P. A., Tabas, L. B., Shepard, R. L., Dantzig, A. H., Deeley, R. G., & Cole, S. P. C. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m202182200 · Cited by 62
Intermediate Structural States Involved in MRP1-mediated Drug Transport
Manciu, L., Chang, X.-B., Buyse, F., Hou, Y., Gustot, A., Riordan, J. R., & Ruysschaert, J. M. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m207963200 · Cited by 62
van Luyn, M. J. A., Müller, M., Renes, J., Meijer, C., Scheper, R. J., Nienhuis, E. F., Mulder, N. H., Jansen, P. L. M., & de Vries, E. G. E. (1998) · International Journal of Cancer · Cited by 62
THE ROLE OF CHEMOTHERAPY FOR METASTATIC BREAST CANCER
Miller, K. D., & Sledge, G. W. (1999) · Hematology/Oncology Clinics of North America · doi:10.1016/s0889-8588(05)70063-0 · Cited by 58
Effect of P-glycoprotein Expression on Sensitivity to Hormones in MCF-7 Human Breast Cancer Cells
Clarke, R. C., Currier, S., Kaplan, O., Lovelace, E., Boulay, V., Gottesman, M. M., & Dickson, R. B. (1992) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/84.19.1506 · Cited by 57
Self-citationDexter, D., Reddy, R. K., Geles, K. G., Bansal, S., Myint, M. A., Rogakto, A., Leighton, J. C., & Goldstein, L. J. (1998) · PubMed · Cited by 57
Schneider, J., González-Roces, S., Pollán, M., Lucas, R., Tejerina, A., Martín, M., & Alba, A. (2001) · Breast Cancer Research · doi:10.1186/bcr293 · Cited by 53
Mross, K. B., Bohn, C., Edler, L., Jonat, W., Queißer, W., Heidemann, E., Goebel, M., & HOSSFELD, D. K. (1993) · Annals of Oncology · doi:10.1093/oxfordjournals.annonc.a058356 · Cited by 51
Wild-type p53-mediated Induction of Rat mdr1bExpression by the Anticancer Drug Daunorubicin
Zhou, G., & Kuo, M. T. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.25.15387 · Cited by 51
Gruol, D. J., & Bourgeois, S. (1994) · Biochemistry and Cell Biology · doi:10.1139/o94-075 · Cited by 50
Warner, E., Hedley, D. W., Andrulis, I. L., Myers, R. E., Trudeau, M. G., Warr, D. G., Pritchard, K. I., Blackstein, M. E., Goss, P. E., Franssen, E., et al. (1998) · PubMed · Cited by 48
Beck, J. F., Bohnet, B., Brügger, D., Bader, P., Dietl, J., Scheper, R. J., Kandolf, R., Liu, C., NIETHAMMER, D., & Gekeler, V. (1998) · British Journal of Cancer · doi:10.1038/bjc.1998.13 · Cited by 46
Chevillard, S., Lebeau, J., Pouillart, P., de Toma, C., Beldjord, C., Asselain, B. J. R., Klijanienko, J., Fourquet, A., Magdelénat, H., & Vielh, P. R. (1997) · PubMed · Cited by 46
Sun, S., Hsieh, J., Tsai, S., Ho, Y., Lee, J.-K., & Kao, C. (2000) · Cancer Letters · doi:10.1016/s0304-3835(00)00356-6 · Cited by 44
Chung, H. C., Rha, S. Y., Kim, J. H., Roh, J. K., Min, J. S., Lee, K. S., Kim, B., & Lee, K. B. (1997) · Breast Cancer Research and Treatment · doi:10.1023/a:1005739525196 · Cited by 44
Cayre, A., Cachin, F., Maublant, J., Mestas, D., Feillel, V., Ferrière, J.-P., Kwiaktowski, F., Chevillard, S., Finat‐Duclos, F., Verrelle, P., et al. (2002) · International Journal of Oncology · doi:10.3892/ijo.20.5.1049 · Cited by 40
Davey, M. W., Hargrave, R. M., & Davey, R. A. (1996) · Leukemia Research · doi:10.1016/0145-2126(96)00023-9 · Cited by 39
P-glycoprotein and MRP1 expression in axillary lymph node metastases of breast cancer patients.
Zöchbauer‐Müller, S., Filipits, M., Rudas, M., Brunner, R., Krajnik, G., Suchomel, R. W., Schmid, K., & Pirker, R. (2001) · PubMed · Cited by 38
Trifluoperazine as a modulator of multidrug resistance in refractory breast cancer
Murren, J. R., Durivage, H. J., Buzaid, A. C., Reiß, M., Flynn, S. D., Carter, D., & Hait, W. N. (1996) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s002800050449 · Cited by 37
Influence of microenvironmental pH on adriamycin resistance.
Alabaster, O., Woods, T., Ortiz-Sanchez, V., & Jahangeer, S. M. (1989) · PubMed · Cited by 35
Mubashar, M., Harrington, K. J., Chaudhary, K. S., Lalani, E., Stamp, G., Sinnett, D., Glass, D. M., & Peters, A. M. (2002) · PubMed · Cited by 34
Kao, C., Tsai, S., Liu, T., Ho, Y., Wang, J., Ho, S., & ChangLai, S.-P. (2001) · PubMed · Cited by 34
Strauss, B. E., & Haas, M. (1995) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1995.2781 · Cited by 33
Manciu, L., Chang, X.-B., Riordan, J. R., & Ruysschaert, J. (2000) · Biochemistry · doi:10.1021/bi001043v · Cited by 32
Gago, F. E., Tello, O. M., Diblasi, Á. M., et al. (1998) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(98)00140-x · Cited by 29
C-7 Analogues of Progesterone as Potent Inhibitors of the P-Glycoprotein Efflux Pump
Leonessa, F., Kim, J.-H., Ghiorghis, A., Kulawiec, R. J., Hammer, C. F., Talebian, A., & Clarke, R. C. (2001) · Journal of Medicinal Chemistry · doi:10.1021/jm010126m · Cited by 28
Self-citationThe MDR1 Downstream Promoter Contains Sequence-Specific Binding Sites for Wild-Type p53
Strauss, B. E., Shivakumar, C., Deb, S., Deb, S., & Haas, M. (1995) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1995.2846 · Cited by 28
Myocardial perfusion imaging with technetium-99m-labeled agents
Maddahi, J., Kiat, H., & Berman, D. S. (1991) · The American Journal of Cardiology · doi:10.1016/s0002-9149(05)80005-0 · Cited by 27
Li, Z., Zhu, Y., & Lit, X.-T. (1997) · Cancer Letters · doi:10.1016/s0304-3835(97)00267-x · Cited by 27
Treatment of Metastatic Breast Cancer
Poncet, B., Colin, C., Bachelot, T., Jaisson‐Hot, I., Derain, L., Magaud, L., Fournel-Federico, C., Mousseau, M., Tigaud, J., Jacquin, J.-P., et al. (2009) · American Journal of Clinical Oncology · doi:10.1097/coc.0b013e31818c08d3 · Cited by 24
Koh, E. H., Chung, H. C., Lee, K. B., Lim, H. Y., Kim, J. H., Roh, J. K., Min, J. S., Lee, K. S., & Kim, B. (1992) · Yonsei Medical Journal · doi:10.3349/ymj.1992.33.2.137 · Cited by 24
Stein, U., Rau, B., Wust, P., Walther, W., & Schlag, P. M. (1999) · International Journal of Cancer · Cited by 20
Botti, G., Chiappetta, G., D’Aiuto, G., de Angelis, E., Matteis, A. D., Montella, M., Picone, A., & Cascione, F. (1993) · Tumori Journal · doi:10.1177/030089169307900312 · Cited by 15
Dexverapamil to overcome epirubicin resistance in advanced breast cancer
Thurlimann, B. J. K., Kröger, N. M., Greiner, J., et al. (1995) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/bf02351063 · Cited by 14
Prognostic and predictive value of p53 and p21 in breast cancer
Elledge, R. M., & Allred, D. C. (1998) · Springer eBooks · doi:10.1007/978-1-4615-5195-9_14 · Cited by 8
Cited by
Deeley, R. G., Westlake, C., & Cole, S. P. C. (2006) · Physiological Reviews · doi:10.1152/physrev.00035.2005 · Cited by 761
Mechanisms of Multidrug Resistance in Cancer
Gillet, J.-P., & Gottesman, M. M. (2010) · Methods in Molecular Biology · doi:10.1007/978-1-60761-416-6_4 · Cited by 685
Mechanisms of Drug Resistance in Cancer Chemotherapy
Luqmani, Y. A. (2005) · Medical Principles and Practice · doi:10.1159/000086183 · Cited by 651
Breast Cancer: Current Perspectives on the Disease Status
Fahad Ullah, M. (2019) · Advances in Experimental Medicine and Biology · doi:10.1007/978-3-030-20301-6_4 · Cited by 598
Taxanes, microtubules and chemoresistant breast cancer
McGrogan, B. T., Gilmartin, B., Carney, D. N., & McCann, A. (2008) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2007.10.004 · Cited by 535
Metadata
- Authors
- Leonessa, F., & Clarke, R.
- Venue
- Endocrine-related cancer
- Publisher
- Bioscientifica
- Published
- 2003-03
- Volume
- 10
- Issue
- 1
- Pages
- 43-73
- ISSN
- 1351-0088 (ISSN-L)
- OpenAlex
- W2127815633
- Cited by
- 259
- References
- 155
- FWCI
- 5.40
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.